Two independent studies have shown that SNHG12 levels were up-regulated (~1.8-fold) in paired human prostate cancer (PCa) tissue samples compared to normal adjacent tissue, and (~2.3-fold) in the DU145 prostate cancer cell line compared to normal prostate cells (47, 48). This evidence concerns the gene SNHG12 and prostate carcinoma.